These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 16029967

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Management of thromboembolism in hematologic malignancies.
    Chong BH, Lee SH.
    Semin Thromb Hemost; 2007 Jun; 33(4):435-48. PubMed ID: 17525901
    [Abstract] [Full Text] [Related]

  • 4. Adverse effects on hemostatic function of drugs used in hematologic malignancies.
    Zakarija A, Kwaan HC.
    Semin Thromb Hemost; 2007 Jun; 33(4):355-64. PubMed ID: 17525893
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Bleeding and thrombosis in acute leukemia: what does the future of therapy look like?
    Rickles FR, Falanga A, Montesinos P, Sanz MA, Brenner B, Barbui T.
    Thromb Res; 2007 Jun; 120 Suppl 2():S99-106. PubMed ID: 18023721
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Management of bleeding complications of hematologic malignancies.
    Green D.
    Semin Thromb Hemost; 2007 Jun; 33(4):427-34. PubMed ID: 17525900
    [Abstract] [Full Text] [Related]

  • 12. Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder.
    Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.
    Pediatr Hematol Oncol; 2008 Jun; 25(4):301-11. PubMed ID: 18484474
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Management of Thrombohemorrhagic Syndromes (THS) in hematologic malignancies.
    Falanga A, Rickles FR.
    Hematology Am Soc Hematol Educ Program; 2007 Jun; ():165-71. PubMed ID: 18024625
    [Abstract] [Full Text] [Related]

  • 17. Disseminated intravascular coagulation in hematologic malignancies.
    Franchini M, Di Minno MN, Coppola A.
    Semin Thromb Hemost; 2010 Jun; 36(4):388-403. PubMed ID: 20614391
    [Abstract] [Full Text] [Related]

  • 18. Thromboembolic complications in pediatric hematologic malignancies.
    Athale UH, Chan AK.
    Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
    [Abstract] [Full Text] [Related]

  • 19. Drug-related thrombosis in hematologic malignancies.
    Nadir Y, Hoffman R, Brenner B.
    Rev Clin Exp Hematol; 2004 Jun 01; 8(1):E4. PubMed ID: 16029970
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.